2017 annual financial data
Vistagen Therapeutics 2017 Operating margin
Direct answer
Operating margin was -819.88%.
Operating income was -10,248,500 USD and net income was -10,255,500 USD.
Operating cash flow was -7,262,100 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,250,000 USD
- Operating income
- -10,248,500 USD
- Net income
- -10,255,500 USD
- Operating cash flow
- -7,262,100 USD